Tesamorelin/Ipamorelin 5mg/500mcg/2.5mg Peptides
Designed for researchers who demand clarity, control, and consistent performance in every vial.
This Tesamorelin and Ipamorelin research peptide blend is provided as a lyophilized (freeze-dried) vial for laboratory use. The neutral, unflavored formulation supports precise protocol development and methodical handling. This listing reflects a labeled strength profile of 5mg/500mcg/2.5mg, enabling disciplined study design without unnecessary complexity.
- Tesamorelin a growth hormone-releasing hormone analog investigated for its ability to stimulate GH pathways and support studies focused on metabolic and body composition mechanisms.
- Ipamorelin a selective GH secretagogue commonly evaluated for targeted GH release in controlled settings, valued for its focused receptor activity in experimental models.
As a non-edible, lyophilized vial, this blend is intended to be reconstituted by qualified personnel using appropriate laboratory technique. Researchers value the clean dissolution profile of lyophilized materials, which facilitates accurate aliquoting, repeatable sampling, and protocol-specific concentration adjustments. The Tesamorelin/Ipamorelin combination offers a complementary framework for investigations into GH-related signaling, allowing teams to explore study endpoints with structured, measurable inputs.
Peptide Scientific Labs prioritizes reliability at every step. Materials are sourced with care and handled under controlled conditions to protect integrity from receipt to final packaging. Each production lot is subjected to rigorous quality reviews for identity and purity, with attention to consistency so results remain comparable across studies. Vials are packaged for stability and traceability, supporting good laboratory practice and audit-ready documentation.
Ingredients: Tesamorelin, Ipamorelin.
For laboratory research use only. Not for human consumption, medical, veterinary, or household use. Follow all applicable regulations and standard operating procedures when handling, reconstituting, and storing research peptides.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is TESA/IPA Blend typically studied for?
Researchers generally study this combination for growth-hormone pulse support, IGF-1-related signaling, and body-composition or recovery-oriented endocrine models. The useful nuance for an FAQ is that blends like this are chosen for pathway complementarity, but study relevance still depends on the exact dose ratio disclosed by the vendor.
What is TESA/IPA Blend?
TESA/IPA Blend combines Tesamorelin, a GHRH analog, with Ipamorelin, a ghrelin-receptor agonist. The purpose of the blend is to bring together two different upstream signals that can influence endogenous growth-hormone release. On a site page, it should be described as a research blend for GH-axis and endocrine studies only.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Peptide Scientific Labs are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
